Login / Signup

Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma.

Brendan D CurtiMarka CrittendenSteven K SeungChristopher B FountainRoxanne PayneShuChing ChangJessica FleserKimberly PhillipsIan MalkasianLyn B DobrunickWalter J Urba
Published in: Journal for immunotherapy of cancer (2021)
NCT01416831.
Keyphrases
  • phase ii study
  • open label
  • locally advanced
  • placebo controlled
  • double blind
  • phase iii
  • rectal cancer
  • phase ii
  • early stage
  • radiation therapy
  • clinical trial
  • squamous cell carcinoma
  • radiation induced
  • study protocol